Inve US ▾

IRADIMED (IRMD) earnings

IRADIMED CORP· Health Care

Results to
Jun 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

IRADIMED earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue20.5 $ million+0.3% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin31.2 %−2.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit5.2 $ million−9.6% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Jun 2026

Price

$87.65 −0.70% · −$0.62

Last close Oct 19, 2026 · US · USD

Performance +19.4% 1Y

$80$90$100Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Aug 26Oct 26Jun 2026 (Q2 FY26) — 31 Jul 2026

1Y: $73.43 on 17 Oct 2025 → $87.65. High $105.15 (10 Feb 2026), low $73.43 (17 Oct 2025).

Previous close
$88.27
52-week range
$74.69 – $105.15
One year
+17.35%

Overview

Symbol
IRMD
Exchange
US
Currency
USD

Your own record

Start an Inve Case for IRADIMED CORP

Free account. Everything above stays public.

Write why you follow IRADIMED CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other US companies filed under I

All 118 companies under I

US companies A–Z · Earnings calls · US earnings-call directory · US sector analysis · What management promised, and delivered